Abstract
IgG4-related disease (IgG4-RD) is a fibro-inflammatory condition characterized by fibrous swelling of affected organs, elevated serum IgG4 concentration in the majority of patients, and a prompt response to corticosteroid therapy. The concept of IgG4-RD as a novel clinical entity emerged at the beginning of the twenty-first century, when Hamano and others noted that, by analogy with sarcoidosis, several seemingly unrelated disorders encompassing a wide range of organs shared common and unique histopathological features. Indeed, many different conditions once regarded as singular entities are now considered part of the IgG4-RD spectrum, such as autoimmune pancreatitis, hypertrophic pachymeningitis, idiopathic retroperitoneal fibrosis, orbital pseudotumor, and Mikulicz’s disease, among others. Vascular involvement has been reported in a proportion of cases of periaortitis and inflammatory aneurysms of the thoracic and abdominal aorta. Given the recent birth of IgG4-RD, little is known with certainty about its immunopathogenesis. A putative pathogenic contribution of the humoral immune response is supported by the rapid clinical responses obtained in these patients with the anti-CD20 monoclonal antibody, rituximab. Novel insights into the pathophysiology of IgG4-RD will likely derive from the identification of possible microbial or self-antigens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551
Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738
Della-Torre E, Lanzillotta M, Doglioni C (2015) Immunology of IgG4-related disease. Clin Exp Immunol 181:191–206. doi:10.1111/cei.12641
Khosroshahi A, Stone JH (2011) Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 23:67–71
Khosroshahi A, Carruthers M, Deshpande V, Unizony S, Bloch DB, Stone JH (2012) Rituximab for the treatment of IgG4-related disease: lessons from ten consecutive patients. Medicine 91:57–66
Khosroshahi A, Bloch DB, Deshpande V, Stone JH (2010) Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755–1762
Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M et al (2014) B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis 74:2236– 2243. doi:10.1136/annrheumdis-2014-205799
Mattoo H, Della-Torre E, Mahajan VS, Stone JH, Pillai S (2014) Circulating Th2 memory cells in IgG4-related disease are restricted to a defined subset of subjects with atopy. Allergy 69:399–402
Della Torre E, Mattoo H, Mahajan VS, Carruthers M, Pillai S, Stone JH (2014) Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69:269–272
Stone JH, Khosroshahi A, Deshpande V, Stone JR (2010) IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res (Hoboken) 62:316–322
Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F (2008) A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 42:1261–1271
Vaglio A, Pipitone N, Salvarani C (2011) Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol 23:1–6
Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH (2014) IgG4-related disease. Annu Rev Pathol 9:315–347
Mattoo H, Mahajan VS, Della-Torre E, Sekigami Y, Carruthers M, Wallace ZS et al (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol 134:679. doi:10.1016/j.jaci.2014.03.034
Wallace ZS, Mattoo H, Carruthers M, Mahajan VS, Della Torre E, Lee H et al (2014) Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis 74:190–195. doi:10.1136/annrheumdis-2014–205233
Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA et al (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74:1171–1177. doi:10.1136/annrheumdis-2014–206605
Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2014) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74:14–18. doi:10.1136/annrheumdis-2013–204907
Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181–1192
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Della Torre, E. (2016). IgG4-Related Disease. In: Dammacco, F., Ribatti, D., Vacca, A. (eds) Systemic Vasculitides: Current Status and Perspectives. Springer, Cham. https://doi.org/10.1007/978-3-319-40136-2_27
Download citation
DOI: https://doi.org/10.1007/978-3-319-40136-2_27
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40134-8
Online ISBN: 978-3-319-40136-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)